REVEAL-CKD: Prevalence and Consequences of Undiagnosed Chronic Kidney Disease

CompletedOBSERVATIONAL
Enrollment

1,006,361

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions
Chronic Kidney Disease
Trial Locations (13)

2040

Research Site, Sydney

20124

Research Site, Milan

28037

Research Site, Madrid

40202

Research Site, Louisville

48108

Research Site, Ann Arbor

60549

Research Site, Frankfurt

92641

Research Site, Boulogne-Billancourt

510515

Research Site, Guangzhou

02140

Research Site, Cambridge

05403-000

Research Site, São Paulo

K7L 3G2

Research Site, Kingston

604-0086

Research Site, Kyoto

E14 4PU

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY